The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Recurrence Rate After Laparoscopic Repair of Large Hiatal Hernia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03025932
Recruitment Status : Enrolling by invitation
First Posted : January 20, 2017
Last Update Posted : November 27, 2023
Sponsor:
Information provided by (Responsible Party):
Prof Urs Zingg, Spital Limmattal Schlieren

Tracking Information
First Submitted Date January 9, 2017
First Posted Date January 20, 2017
Last Update Posted Date November 27, 2023
Study Start Date January 2016
Estimated Primary Completion Date January 31, 2027   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: January 17, 2017)
Radiological recurrence rate of hiatal hernia determined by computer tomography (CT) scan [ Time Frame: minimum 1 year after surgery ]
To evaluate the radiological recurrence rate of hiatal hernia at least one year after surgery by performing a computer tomography
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: June 3, 2020)
  • Quality of life by GIQLI [ Time Frame: minimum 1 year after surgery ]
    Estimate the quality of life using a standardized questionnaire (Gastrointestinal Qualitiy of Life Index = GIQLI) at least one year after surgery
  • Clinical outcome [ Time Frame: minimum 1 year after surgery ]
    Evaluate the clinical outcome at least one year after surgery by examining the patient and asking targeted questions on the symptoms regarding the former hiatal hernia (using visual analogue scale questions on dysphagia, meteorism, bloating, reflux and retrosternal pain). Furthermore the patients are asked about their general satisfaction regarding the performed surgical intervention.
  • Peri- and postoperative morbidity / mortality [ Time Frame: minimum 1 year after surgery ]
    Evaluate the peri- and postoperative morbidity and mortality from the patient records and a clinical examination
Original Secondary Outcome Measures
 (submitted: January 17, 2017)
  • Quality of life [ Time Frame: minimum 1 year after surgery ]
    Estimate the quality of life using a standardized questionnaire (Gastrointestinal Qualitiy of Life Index = GIQLI) at least one year after surgery
  • Clinical outcome [ Time Frame: minimum 1 year after surgery ]
    Evaluate the clinical outcome at least one year after surgery by examining the patient and asking targeted questions on the symptoms regarding the former hiatal hernia (using visual analogue scale questions on dysphagia, meteorism, bloating, reflux and retrosternal pain). Furthermore the patients are asked about their general satisfaction regarding the performed surgical intervention.
  • Peri- and postoperative morbidity / mortality [ Time Frame: minimum 1 year after surgery ]
    Evaluate the peri- and postoperative morbidity and mortality from the patient records and a clinical examination
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Recurrence Rate After Laparoscopic Repair of Large Hiatal Hernia
Official Title Clinical vs. Radiological Recurrence Rate After Laparoscopic Repair of Large Hiatal Hernia With Mesh and Anterior Fundoplication
Brief Summary Patients who underwent laparoscopic repair of large hiatal hernias and anterior fundoplication with mesh are examined for their recurrence rate one year after surgery.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Retrospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Inclusion of all patients older than 18 years with initial large hiatal hernia (>20% herniated into thoracic cavity) and laparoscopic hiatoplasty with mesh and anterior fundoplication
Condition Hiatal Hernia Large
Intervention Procedure: repair of giant hiatal hernia with mesh and anterior fundoplication
Study Groups/Cohorts Patient cohort
Patients who underwent laparoscopic hernia repair of giant hiatal hernia with mesh and received anterior fundoplication
Intervention: Procedure: repair of giant hiatal hernia with mesh and anterior fundoplication
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Enrolling by invitation
Estimated Enrollment
 (submitted: September 21, 2021)
200
Original Actual Enrollment
 (submitted: January 17, 2017)
50
Estimated Study Completion Date January 31, 2027
Estimated Primary Completion Date January 31, 2027   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Age older than 18 years
  • Initially suffering from large hiatal hernia (>20% of the stomach in the thoracic cavity)
  • Performance of laparoscopic hiatal hernia repair with mesh and anterior fundoplication
  • Informed Consent as documented by signature (Appendix: Informed Consent Form)

Exclusion Criteria:

  • Performance of any other anti-reflux surgery such as Toupet- or Nissen-fundoplication
  • Performance of anterior fundoplication without mesh
  • Women who meet the inclusion criteria but are pregnant or breast feeding or have the intention to become pregnant during the course of the study
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT03025932
Other Study ID Numbers 2016-01510
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement
Plan to Share IPD: No
Current Responsible Party Prof Urs Zingg, Spital Limmattal Schlieren
Original Responsible Party PD Dr. Urs Zingg, Spital Limmattal Schlieren, PD Dr. med.
Current Study Sponsor Prof Urs Zingg
Original Study Sponsor PD Dr. Urs Zingg
Collaborators Not Provided
Investigators
Principal Investigator: Urs Zingg Principal Investigator
PRS Account Spital Limmattal Schlieren
Verification Date November 2023